Biotechnology News

September 6, 2012

PITTSBURGH--(BUSINESS WIRE)--Precision Therapeutics has released the results of a study that determines whether ChemoFx® results change from primary diagnosis to recurrence of disease in gynecological tumors with intervening administration of...

September 6, 2012

HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology today announced the successful...

September 6, 2012

HACKENSACK, N.J.--(BUSINESS WIRE)--ADMA Biologics, Inc. (ADMA), a late-stage biotechnology company focused on the development and commercialization of human plasma and plasma-derived therapeutics, today announced it is scheduled to present at the...

September 6, 2012

FRAMINGHAM, Mass.--(BUSINESS WIRE)--AB Sciex and Sigma-Aldrich Announce Distribution Agreement

September 6, 2012

PALO ALTO, Calif.--(BUSINESS WIRE)--New Interventional Medical Device That Gently and Simply Treats Chronic Sinusitis Is Now Available in Europe.

September 6, 2012

NEWTOWN, Pa.--(BUSINESS WIRE)--Isis Pharmaceuticals is expanding its current use of BioClinica's Express Electronic Data Capture (EDC) solution to a broader range of upcoming clinical trials.

September 6, 2012

SAN RAMON, Calif.--(BUSINESS WIRE)--Estech, a leading provider of minimally invasive cardiac ablation devices, today announced the market release of its COBRA Fusion™ ablation system. This revolutionary technology is the first of its kind to use...

September 6, 2012

KARLSRUHE, Germany--(BUSINESS WIRE)--Findings by French scientists suggest that protection against Alzheimer´s disease can only be expected following long-term regular use of Ginkgo Extract EGb 761®. Use for a minimum of four years nearly halved...

September 6, 2012

BERKELEY, Calif.--(BUSINESS WIRE)--Aduro BioTech, Inc. announces the award of a Congressionally Directed Medical Research Programs (CDMRP) grant from the Department of Defense. The grant of $867,846 will be used to complete the preclinical...

September 6, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (OTC/BB: NVIV), a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI) and neurotrauma conditions, today announced that CEO Frank Reynolds...

September 6, 2012

VANCOUVER, British Columbia--(BUSINESS WIRE)--Zymeworks Inc. today announced the successful achievement of a research milestone in its collaboration with Merck, known as MSD outside of the United States and Canada, related to Zymeworks’...

September 6, 2012

VANCOUVER, British Columbia--(BUSINESS WIRE)--Zymeworks Inc., a privately held biotherapeutics company focused on the development of best-in-class bi-specific antibody therapeutics and multi-valent protein therapeutics, today announced the...

September 6, 2012

SOUTHAMPTON, England--(BUSINESS WIRE)--Karus Therapeutics, a leader in the development of innovative medicines for the treatment of inflammatory disease and cancer, announces the closing of its Series B investment, which includes a first tranche...

September 6, 2012

SHANGHAI--(BUSINESS WIRE)--Generon Corporation announced the initiation of a Phase I clinical trial for F-652. F-652 is a recombinant protein containing a human interleukin-22 dimer, a first in class candidate, for hepatitis.

September 6, 2012

BOSTON & GENEVA--(BUSINESS WIRE)--PHT Corporation announced a 36% increase in revenues in the 1st half of 2012 over the same period last year. Bookings rose 27%. Global headcount expanded by 29%.

September 6, 2012

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: The Extraordinary General Meeting (EGM) of Fingerprint Cards AB (STO:FINGB) (publ) (the “Company”) has approved a private placement of share warrants and has resolved to approve the transfer of share...

September 6, 2012

COPENHAGEN, Denmark--(BUSINESS WIRE)--Symphogen A/S, a private biopharmaceutical company developing recombinant antibody mixtures, a class of antibody therapeutics under investigation for the treatment or prophylaxis of serious human diseases...

September 6, 2012

VISTA, Calif. & OXFORD, England--(BUSINESS WIRE)--Aperio ePathology NETWORK to improve communication among pathologists, pathology sub-specialists and other physicians.

September 5, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--NeuroMetrix, Inc. (Nasdaq: NURO), www.neurometrix.com, a medical device company focused on the diagnosis and treatment of the neurological...

September 5, 2012

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that its corporate presentation will be webcast from the Morgan Stanley Global Healthcare Conference in New York. John F. Milligan, PhD, Gilead’s President...

September 5, 2012

DUBLIN, Ohio--(BUSINESS WIRE)--Navidea Biopharmaceuticals to Present at Upcoming Investor Conferences to Provide Business and Development Program Updates

September 5, 2012

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Senesco Technologies, Inc. (“Senesco” or the “Company”) (NYSE MKT: SNT) announced that the Company will be presenting at the Rodman & Renshaw Annual Global Investment Conference being held at the Waldorf...

September 5, 2012

OTTAWA, Ontario--(BUSINESS WIRE)--Nordion Inc. (TSX: NDN) (NYSE: NDZ): Revenue of $67.1 million, an increase of 0.5% over Q3 2011 Adjusted earnings per share, excluding specified items, increased to $0.25, up from $0.15 in the third quarter...

September 5, 2012

ANN ARBOR, Mich.--(BUSINESS WIRE)--Online Tech, the leader in secure and compliant data hosting services, has taken another step to differentiate itself from its competitors. The Ann Arbor, Mich.-based data center expanded its compliant computing...

September 5, 2012

COLD SPRING HARBOR, N.Y.--(BUSINESS WIRE)--As part of a huge collaborative effort called ENCODE (Encyclopedia of DNA Elements), a research team at CSHL has analyzed all the RNA messages, called transcripts, produced within human cells.

September 5, 2012

HOUSTON--(BUSINESS WIRE)--Smart Imaging Technologies has signed a license agreement with Leica Microsystems and added support for Leica Slide Scanners to Simagis Live Digital Pathology Servers.

September 5, 2012

PRINCETON, N.J.--(BUSINESS WIRE)--Derma Sciences, Inc. (Nasdaq: DSCI), a medical device and pharmaceutical company focused on advanced wound care announced today that Edward J. Quilty, the Company’s chief executive officer will present a...

September 5, 2012

DAVIS, Calif.--(BUSINESS WIRE)--Simplify and improve your clinical laboratory with single-step, direct ELISA measurement of Free Testosterone from Gold Standard Diagnostics (GSD)

September 5, 2012

ALAMEDA, Calif.--(BUSINESS WIRE)--Penumbra Coil 400 enables endovascular surgeons to implant fewer coils, during shorter procedures, and achieve better results significantly improving minimally invasive brain aneurysm treatment.

September 5, 2012

WILMINGTON, N.C.--(BUSINESS WIRE)--Myo Technologies, LLC Introduces Non-Invasive Microcurrent Skin Toning Treatment and Botanical Skin Care Products for Medical Professional Use, Pre- and Post-Surgery

September 5, 2012

LEBANON, N.H.--(BUSINESS WIRE)--ImmuNext - Janssen Biotech partnership to develop novel therapeutics that modulate the immune system for the treatment of cancer.

September 5, 2012

TORONTO--(BUSINESS WIRE)--New Enterprise Cloud Infrastructure Service Contract with SunGard Sets Stage for the North American Launch of the HeartCheckTM PEN SMART Monitoring Service

September 5, 2012

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Sunovion Pharmaceuticals Inc. (Sunovion) today announced that it has completed the company’s acquisition, by merger, of Elevation Pharmaceuticals, Inc. (Elevation). Elevation is now a wholly-owned subsidiary...

September 5, 2012

SANTA CLARA, Calif.--(BUSINESS WIRE)--XenoPort, Inc. (Nasdaq: XNPT) announced today that it will provide access via the World Wide Web to its presentation at the Morgan Stanley Global Healthcare Conference. The live presentation will occur at 12:...

September 5, 2012

SAN FRANCISCO--(BUSINESS WIRE)--FibroGen, Inc., on Monday, September 3rd, presented the most recent results from its Phase 2 trial of FG-3019 as an oral presentation at the European Respiratory Society Annual Congress in Vienna, Austria. The...

September 5, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Desktop DNA sequencing company GnuBIO moves towards commercialization of the first no prep desktop DNA sequencer. The company is moving to a larger facility in Cambridge, MA - Kendall Square.

September 5, 2012

SAN FRANCISCO--(BUSINESS WIRE)--ClinStar to Present a Comparison of Study Start-Up in Emerging Markets with at Outsourcing Clinical Trials New England Conference Followed by a Seminar on Optimizing Time and Money in Clinical Trials

September 5, 2012

EXTON, Pa.--(BUSINESS WIRE)--BioTrends Research Group, one of the world’s leading research and advisory firms for specialized biopharmaceutical issues, finds that Roche/Genentech’s Perjeta (pertuzumab) which has been available in the U.S. for one...

September 5, 2012

VALLEY FORGE, Pa.--(BUSINESS WIRE)--Vanguard announced today that Edward P. Owens, CFA, portfolio manager of Vanguard Health Care Fund, plans to retire on December 31, 2012.

September 5, 2012

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE: BAX) previously announced that it will host its 2012 Investor Conference on Tuesday, October 9, 2012 at the Ritz-Carlton Hotel in Chicago, IL, from 8:00 a.m. until approximately 3...

September 5, 2012

OKLAHOMA CITY--(BUSINESS WIRE)--The new Magellan(TM) prosthetic leg from Orthocare Innovations brings novel approach by mimicking key features of the human ankle and offers wireless connectivity.

September 5, 2012

NEW HAVEN, Conn.--(BUSINESS WIRE)--Rib-X's antibiotic development programs will be featured in a total of 16 posters and presentations at the 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)

September 5, 2012

MANCHESTER, England--(BUSINESS WIRE)--Gentronix Ltd. today announced the company's first contracted screening project in Japan, with a major Japanese pharmaceutical manufacturer, Kowa Company, Ltd.

September 5, 2012

CHELSEA, Mass.--(BUSINESS WIRE)--Civitas Therapeutics, a private company developing inhaled therapeutics with the proven ARCUS(TM) dry powder platform, today announced that Bryan Stuart has been appointed Chief Business Officer.

September 5, 2012

WAYNE, Pa.--(BUSINESS WIRE)--Safeguard Scientifics to host Investor Day 2012 on October 9th. RSVP at www.safeguard.com/InvestorDay2012. Join us to...

September 5, 2012

BOTHELL, Wash.--(BUSINESS WIRE)--Seattle Genetics, Inc. (Nasdaq:SGEN) announced today that management will present at three investor conferences in September. The presentations will be webcast live and available for replay from Seattle Genetics’...

September 5, 2012

RALEIGH, N.C.--(BUSINESS WIRE)--LipoScience, Inc. today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration to market the Vantera® Clinical Analyzer.